We are monitoring the impact of COVID-19 on North America Medical Cannabis Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2021
ID: 10009
Share on
Share on

North America Medical Cannabis Market Research Report - Segmented By Species, Derivatives, Application, Route of Administration & Country (US, Canada) – Industry Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: August, 2021
ID: 10009
Pages: 100

North America Medical Cannabis Market Size & Growth (2021 to 2026):

The North America Medical cannabis market Size is valued at USD 5.61 billion in 2021and is expected to reach USD 15.29 billion by 2026. The medical cannabis market size in North America is projected to grow at a CAGR of 22.23 % from 2021 to 2026.

The medical cannabis market is driven by factors like a wide range of cannabis products to the customers that are likely to drive the market. Increasing research and development activities, developing a safe form of cannabis products, act as encouraging the medical cannabis market growth. FDA approvals for the cannabis-related drug therapies, or the products related to cannabis may surge the growth. The cannabis treatment provides benefits, especially for elderly people with relief from symptoms like sleep difficulties, vomiting, nausea, chronic pain, and many more, which fosters the growth of medical cannabis of this region. The growth is due to increasing awareness among the public regarding medical cannabis is it has therapeutic capability in preventing and treating long disorders.

Strict regulatory and approval processes for the product launches, devices, and therapies associated with the market may hamper the growth over the period. Side-affects post-treatment may also hinder growth. Lack of awareness regarding the medical cannabis market is restraining growth.

This research report on the North America Medical Cannabis Market has been segmented and sub-segmented into the following categories:

By Species:

  • Indica
  • Satiiva
  • Hybrid

By Derivatives:

  • Cannabidiol (CBD)
  • Tetrahydrocannabinol (THC)
  • Others

By Application:

  • Cancer
  • Arthritis
  • Epilepsy
  • Migraine

By End User:

  • Pharmaceutical Industry
  • Research and Development Centers
  • Others

By Route of Administration:

  • Oral Solutions and Capsules
  • Smoking
  • Vaporizers
  • Topicals
  • Others

By Country:

  • US
  • Canada
  • Rest of North America

Regional Analysis

North America's medical cannabis market is expected to have the highest shares of the market. The region is estimated to have its dominance over the period due to increasing investments made by the public and private sectors for research and development over the regional period. Moreover, this region's growth is offered by the profitable outcomes and opportunities for the entry of new industries into the market. The growing demand for cannabis products among consumers in both the countries of the US and Canada is to surge the market growth over the analysis period.

US medical cannabis market is expected to dominate the market with a total share of 96% in the North America Medical Cannabis market over the regional period. This country owes to the growing legalization of cannabis products for the medical and recreational use of different states of the US. Common increases of pain, particularly in this country is driving the market.

Canada medical cannabis market is expected to have the highest growth rate during the period, followed by the US. The growing availability of raw materials and creating awareness over the usage of these products in the appropriate dosage form are enhancing the growth rate of the market. 

Top Companies leading North America Medical Cannabis Market Profiled in the Report are BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc., Canopy Growth Corporation, Insys Therapeutics, Inc., Aphria, Inc., MGC Pharmaceuticals Limited, GW Pharmaceuticals, plc.

  1. Introduction
    1. North America Medical Cannabis Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. North America Medical Cannabis Market Drivers
    2. North America Medical Cannabis Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. North America Medical Cannabis Market Segmentation
    1. By Species
      1. Indica
      2. Satiiva
      3. Hybrid
      4. Y-o-Y Growth Analysis, By Species
      5. North America Medical Cannabis Market Attractiveness Analysis, By Species
      6. North America Medical Cannabis Market Share Analysis, By Species
    2. By Derivatives
      1. Cannabidiol (CBD)
      2. Tetrahydrocannabinol (THC)
      3. Others
      4. Y-o-Y Growth Analysis, By Derivatives
      5. North America Medical Cannabis Market Attractiveness Analysis, By Derivatives
      6. North America Medical Cannabis Market Share Analysis, By Derivatives
    3. By Application
      1. Cancer
      2. Arthritis
      3. Epilepsy
      4. Migraine
      5. Y-o-Y Growth Analysis, By Application
      6. North America Medical Cannabis Market Attractiveness Analysis, By Application
      7. North America Medical Cannabis Market Share Analysis, By Application
    4. By End User
      1. Pharmaceutical Industry
      2. Research and Development Centers
      3. Others
      4. Y-o-Y Growth Analysis, By End User
      5. North America Medical Cannabis Market Attractiveness Analysis, By End User
      6. North America Medical Cannabis Market Share Analysis, By End User
    5. By Route of Administration
      1. Oral Solutions and Capsules
      2. Smoking
      3. Vaporizers
      4. Topicals
      5. Y-o-Y Growth Analysis, By Route of Administration
      6. North America Medical Cannabis Market Attractiveness Analysis, Route of Administration
      7. North America Medical Cannabis Market Share Analysis, Route of Administration
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Species
        3. By Derivatives
        4. By Application
        5. By End-User
        6. By Route of Administration
      4. North America Medical Cannabis Market Attractiveness Analysis 
        1. By Geographical Area
        2. By Species
        3. By Derivatives
        4. By Application
        5. By End-User
        6. By Route of Administration
      5.      North America Medical Cannabis Market Share Analysis              
        1. By Geographical Area
        2. By Species
        3. By Derivatives
        4. By Application
        5. By End-User
        6. By Route of Administration
    2. North America
      1. Introduction
      2. US
      3. Canada
      4. Rest of North America
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. North America Medical Cannabis Market Leaders' Analysis
    1. BOL Pharma
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Tilray
    3. Medreleaf Corporation
    4. Aurora Cannabis, Inc
    5. Canopy Growth Corporation
    6. Insys Therapeutics, Inc
    7. Aphria, Inc
    8. MGC Pharmaceuticals Limited
    9. GW Pharmaceuticals, plc
  9. Competitive Landscape
    1. North America Medical Cannabis Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. North America Medical Cannabis Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures  
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • Segment-level analysis in terms of Type, application, end user and region along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. North America Medical Cannabis Market Market By Species, From 2021 to 2026 ( USD Billion )
  2. North America Indica Market By Region, From 2021 to 2026 ( USD Billion )
  3. North America Satiiva Market By Region, From 2021 to 2026 ( USD Billion )
  4. North America Hybrid Market By Region, From 2021 to 2026 ( USD Billion )
  5. North America Medical Cannabis Market Market By Derivatives, From 2021 to 2026 ( USD Billion )
  6. North America Cannabidiol (CBD) Market By Region, From 2021 to 2026 ( USD Billion )
  7. North America Tetrahydrocannabinol (THC) Market By Region, From 2021 to 2026 ( USD Billion )
  8. North America Others Market By Region, From 2021 to 2026 ( USD Billion )
  9. North America Medical Cannabis Market Market By Application, From 2021 to 2026 ( USD Billion )
  10. North America Cancer Market By Region, From 2021 to 2026 ( USD Billion )
  11. North America Arthritis Market By Region, From 2021 to 2026 ( USD Billion )
  12. North America Epilespy Market By Region, From 2021 to 2026 ( USD Billion )
  13. North America Migraine Market By Region, From 2021 to 2026 ( USD Billion )
  14. North America Medical Cannabis Market Market By End-User, From 2021 to 2026 ( USD Billion )
  15. North America Pharmaceutical Industry Market By Region, From 2021 to 2026 ( USD Billion )
  16. North America Research and Development Centers Market By Region, From 2021 to 2026 ( USD Billion )
  17. North America others Market By Region, From 2021 to 2026 ( USD Billion )
  18. North America Medical Cannabis Market Market By Route of Administration, From 2021 to 2026 ( USD Billion )
  19. North America Oral Solutions and Capsules Market By Region, From 2021 to 2026 ( USD Billion )
  20. North America Smoking Market By Region, From 2021 to 2026 ( USD Billion )
  21. North America Vaporizers Market By Region, From 2021 to 2026 ( USD Billion )
  22. North America Topicals Market By Region, From 2021 to 2026 ( USD Billion )
  23. North America others Market By Region, From 2021 to 2026 ( USD Billion )
  24. United States Medical Cannabis Market Market By Species, From 2021 to 2026 ( USD Billion )
  25. United States Medical Cannabis Market Market By Derivatives, From 2021 to 2026 ( USD Billion )
  26. United States Medical Cannabis Market Market By Application, From 2021 to 2026 ( USD Billion )
  27. United States Medical Cannabis Market Market By End-User, From 2021 to 2026 ( USD Billion )
  28. United States Medical Cannabis Market Market By Route of Administration, From 2021 to 2026 ( USD Billion )
  29. Canada Medical Cannabis Market Market By Species, From 2021 to 2026 ( USD Billion )
  30. Canada Medical Cannabis Market Market By Derivatives, From 2021 to 2026 ( USD Billion )
  31. Canada Medical Cannabis Market Market By Application, From 2021 to 2026 ( USD Billion )
  32. Canada Medical Cannabis Market Market By End-User, From 2021 to 2026 ( USD Billion )
  33. Canada Medical Cannabis Market Market By Route of Administration, From 2021 to 2026 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample